Specific niche view of the structured sector hierarchy. Useful for precedent work where broader sector slices include too much noise.
| Target | Buyer / Investor | Sector | Geo | Transaction size | EV / EBITDA |
|---|---|---|---|---|---|
| Reveal Genomics | Hologic | Bio Diagnostics & Testing | $65.0M – $88.0M | n/m | |
| Prenatal Health testing business of Myriad Genetics Inc. | LabCorp Holdings Inc. | Bio Diagnostics & Testing | $210M | 7× – 9× | |
| BD's Biosciences & Diagnostic Solutions business | Waters Corp. | Bio Diagnostics & Testing | $0.0M | 11× – 15× | |
| Proscia | Agilent | Bio Diagnostics & Testing | $270M | n/m | |
| AEG Identification Systems Ltd | Unified Information Devices (UID) | Bio Diagnostics & Testing | $115M – $155M | 10× – 14× | |
| Microbiology business from Thermo Fisher Scientific | Astorg | Bio Diagnostics & Testing | $1,352M – $1,829M | 11× – 14× | |
| Bactéries et Aliments | Carso | Bio Diagnostics & Testing | $196M – $265M | 6× – 8× | |
| Convergent Genomics, Inc. | Veracyte, Inc. | Bio Diagnostics & Testing | $33.1M – $44.8M | n/m | |
| Xegen | Clean Cells, Clean Biologics, ArchiMed | Bio Diagnostics & Testing | $9.4M – $12.4M | 6× – 8× | |
| Argonaut’s diagnostics division | 1315 Capital | Bio Diagnostics & Testing | $67.1M – $90.8M | 9× – 12× |
Bins are observed deal frequencies across disclosed transactions. Use as a directional reference, not a target valuation.
Use the directory on the recent deals hub to switch between countries, sectors and sub-sectors. A free account unlocks the structured filters that go beyond the public view.